Qpex Biopharma

qpex biopharma, inc. is a san diego-based biopharmaceutical company dedicated to the discovery and development of innovative anti-infective therapies, with a pipeline of best-in-class agents addressing critical needs for treatment of infectious diseases in the inpatient and outpatient settings. qpex was launched in 2018 with investments from new enterprise associates, adams street partners, lyzz capital, hatteras venture partners and stanford university daper fund. the company’s scientists and clinicians have a record of deep expertise in the discovery and development of anti-infective agents, and an extensive record of working with public- private partnerships, including partnerships with the biomedical advanced research and development authority (barda) that led to the first approved antimicrobial drug product under that program in 2017.